Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity

V. Macavei, C. Hyams, J. Ullah, T. O'Shaughnessy, V. White, J. Potter, N. Jayasekera, H. Kunst (London, United Kingdom)

Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Session: Tuberculosis: from diagnosis to therapy and prevention
Session type: Poster Discussion
Number: 3055
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Macavei, C. Hyams, J. Ullah, T. O'Shaughnessy, V. White, J. Potter, N. Jayasekera, H. Kunst (London, United Kingdom). Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity. Eur Respir J 2014; 44: Suppl. 58, 3055

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


Latent TB infection in health care TB workers
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016


Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013



The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015